Report overview
Cell banking systems are set up to assure that a uniform population of cells is preserved, their integrity is maintained, and a sufficient supply of material is accessible for the life of the product. Biosafety testing is performed on cell lines at multiple passages. A cell bank comprises of a storage facility for cells extracted from different body fluids and organ tissue so that they can be used in the future. Stored cells contain detailed characterization of the cell line thereby decreasing chances of cross contamination. And GMP cell banking services consists of outsourcing gathering, storing, characterization, and testing facilities of cell lines, tissues, and cells. GMP basically stands for ?Good Manufacturing Practice.?
This report contains market size and forecasts of GMP Cell Banking in Global, including the following market information:
Global GMP Cell Banking Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global GMP Cell Banking market was valued at 583.9 million in 2022 and is projected to reach US$ 1269.3 million by 2030, at a CAGR of 11.7% during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Mammalian Cell Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of GMP Cell Banking include Charles River, Thermo Fisher, Lonza, Wuxi Apptec, Eurofins Scientific, Merck KGaA, SGS Life Sciences, Sartorius and Catalent, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the GMP Cell Banking companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GMP Cell Banking Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global GMP Cell Banking Market Segment Percentages, by Type, 2022 (%)
Mammalian Cell
Microbial Cell
Insect Cell
Others
Global GMP Cell Banking Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global GMP Cell Banking Market Segment Percentages, by Application, 2022 (%)
Biopharmaceutical Companies
Contract Manufacturing Organizations
Global GMP Cell Banking Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global GMP Cell Banking Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies GMP Cell Banking revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies GMP Cell Banking revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Charles River
Thermo Fisher
Lonza
Wuxi Apptec
Eurofins Scientific
Merck KGaA
SGS Life Sciences
Sartorius
Catalent
Goodwin Biotechnology
Texcell
